Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 81

1.

Response to "Clinical genome-wide sequencing: don't throw out the baby with the bathwater".

Wilson BJ, Miller FA, Rousseau F.

J Clin Epidemiol. 2017 Sep 11. pii: S0895-4356(17)30971-X. doi: 10.1016/j.jclinepi.2017.08.019. [Epub ahead of print]

PMID:
28912001
2.

Clinical genomic sequencing as a routine technology for case finding and diagnosis in unselected patient populations should not proceed without formal comparative evaluation of health outcomes and system impacts.

Wilson BJ, Miller FA, Rousseau F.

J Clin Epidemiol. 2017 Sep 1. pii: S0895-4356(17)30970-8. doi: 10.1016/j.jclinepi.2017.08.018. [Epub ahead of print]

PMID:
28870871
3.

Anticipating health innovations in 2030-2040: Where does responsibility lie for the publics?

Lehoux P, Miller FA, Grimard D, Gauthier P.

Public Underst Sci. 2017 Aug 1:963662517725715. doi: 10.1177/0963662517725715. [Epub ahead of print]

PMID:
28795612
4.

Understanding relevance of health research: considerations in the context of research impact assessment.

Dobrow MJ, Miller FA, Frank C, Brown AD.

Health Res Policy Syst. 2017 Apr 17;15(1):31. doi: 10.1186/s12961-017-0188-6.

5.

Psychosocial Response to Uncertain Newborn Screening Results for Cystic Fibrosis.

Hayeems RZ, Miller FA, Barg CJ, Bombard Y, Carroll JC, Tam K, Kerr E, Chakraborty P, Potter BK, Patton S, Bytautas JP, Taylor L, Davies C, Milburn J, Price A, Gonska T, Keenan K, Ratjen F, Guttmann A.

J Pediatr. 2017 May;184:165-171.e1. doi: 10.1016/j.jpeds.2017.01.049. Epub 2017 Mar 6.

PMID:
28279431
6.

Pediatric Insulin Pump Therapy: Reflecting on the First 10 Years of a Universal Funding Program in Ontario.

Shulman R, Miller FA, Stukel TA, Daneman D, Guttmann A.

Healthc Q. 2017;19(4):6-9.

PMID:
28130944
7.
8.

Managing sickle cell carrier results generated through newborn screening in Ontario: a precedent-setting policy story.

Hayeems RZ, Moore Hepburn C, Chakraborty P, Odame I, Clarke J, Miller FA, Brown AD.

Genet Med. 2017 Jun;19(6):625-627. doi: 10.1038/gim.2016.162. Epub 2016 Oct 20. No abstract available.

PMID:
27763632
9.

An Ecological and Human Biomonitoring Investigation of Mercury Contamination at the Aamjiwnaang First Nation.

Cryderman D, Letourneau L, Miller F, Basu N.

Ecohealth. 2016 Dec;13(4):784-795. Epub 2016 Sep 19.

PMID:
27645755
10.

A secondary benefit: the reproductive impact of carrier results from newborn screening for cystic fibrosis.

Bombard Y, Miller FA, Barg CJ, Patton SJ, Carroll JC, Chakraborty P, Potter BK, Tam K, Taylor L, Kerr E, Davies C, Milburn J, Ratjen F, Guttmann A, Hayeems RZ.

Genet Med. 2017 Apr;19(4):403-411. doi: 10.1038/gim.2016.125. Epub 2016 Sep 8.

11.

How does venture capital operate in medical innovation?

Lehoux P, Miller FA, Daudelin G.

BMJ Innov. 2016 Jul;2(3):111-117. Epub 2016 Apr 15.

12.

Low socioeconomic status is associated with adverse events in children and teens on insulin pumps under a universal access program: a population-based cohort study.

Shulman R, Stukel TA, Miller FA, Newman A, Daneman D, Wasserman JD, Guttmann A.

BMJ Open Diabetes Res Care. 2016 Jun 22;4(1):e000239. doi: 10.1136/bmjdrc-2016-000239. eCollection 2016.

13.

Parent Experience With False-Positive Newborn Screening Results for Cystic Fibrosis.

Hayeems RZ, Miller FA, Barg CJ, Bombard Y, Kerr E, Tam K, Carroll JC, Potter BK, Chakraborty P, Davies C, Milburn J, Patton S, Bytautas JP, Taylor L, Price A, Gonska T, Keenan K, Ratjen F, Guttmann A.

Pediatrics. 2016 Sep;138(3). pii: e20161052. doi: 10.1542/peds.2016-1052. Epub 2016 Aug 2.

14.

Resources and population served: a description of the Ontario Paediatric Diabetes Network.

Shulman R, Miller FA, Stukel TA, Daneman D, Guttmann A.

CMAJ Open. 2016 Apr 19;4(2):E141-6. doi: 10.9778/cmajo.20150006. eCollection 2016 Apr-Jun.

15.

Using Newborn Screening Bloodspots for Research: Public Preferences for Policy Options.

Hayeems RZ, Miller FA, Barg CJ, Bombard Y, Cressman C, Painter-Main M, Wilson B, Little J, Allanson J, Avard D, Giguere Y, Chakraborty P, Carroll JC.

Pediatrics. 2016 Jun;137(6). pii: e20154143. doi: 10.1542/peds.2015-4143. Epub 2016 May 17.

16.

The health system impact of false positive newborn screening results for medium-chain acyl-CoA dehydrogenase deficiency: a cohort study.

Karaceper MD, Chakraborty P, Coyle D, Wilson K, Kronick JB, Hawken S, Davies C, Brownell M, Dodds L, Feigenbaum A, Fell DB, Grosse SD, Guttmann A, Laberge AM, Mhanni A, Miller FA, Mitchell JJ, Nakhla M, Prasad C, Rockman-Greenberg C, Sparkes R, Wilson BJ, Potter BK; Canadian Inherited Metabolic Diseases Research Network.

Orphanet J Rare Dis. 2016 Feb 3;11:12. doi: 10.1186/s13023-016-0391-5.

17.

Insulin pump use and discontinuation in children and teens: a population-based cohort study in Ontario, Canada.

Shulman R, Stukel TA, Miller FA, Newman A, Daneman D, Guttmann A.

Pediatr Diabetes. 2017 Feb;18(1):33-44. doi: 10.1111/pedi.12353. Epub 2016 Jan 8.

PMID:
26748950
18.

Valuing technology: A qualitative interview study with physicians about insulin pump therapy for children with type 1 diabetes.

Shulman R, Miller FA, Daneman D, Guttmann A.

Health Policy. 2016 Jan;120(1):64-71. doi: 10.1016/j.healthpol.2015.10.006. Epub 2015 Nov 10.

PMID:
26563632
19.

Governing population screening in an age of expansion: The case of newborn screening.

Miller FA, Cressman C, Hayeems R.

Can J Public Health. 2015 Apr 29;106(4):e244-8. doi: 10.17269/cjph.106.4897.

PMID:
26285197
20.

Child and family experiences with inborn errors of metabolism: a qualitative interview study with representatives of patient groups.

Khangura SD, Tingley K, Chakraborty P, Coyle D, Kronick JB, Laberge AM, Little J, Miller FA, Mitchell JJ, Prasad C, Siddiq S, Siriwardena K, Sparkes R, Speechley KN, Stockler S, Trakadis Y, Wilson BJ, Wilson K, Potter BK; Canadian Inherited Metabolic Diseases Research Network (CIMDRN).

J Inherit Metab Dis. 2016 Jan;39(1):139-47. doi: 10.1007/s10545-015-9881-1. Epub 2015 Jul 25.

Supplemental Content

Loading ...
Support Center